Literature DB >> 6589010

Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukaemia.

B Nilsson.   

Abstract

A 30-year-old woman was diagnosed as having an acute promyelocytic leukaemia in September 1981. Chemotherapeutic courses of daunomycin, ara-C, thioguanine and prednisolone were administered, resulting in a complete remission. A relapse occurred in January 1982, and chemotherapy did not lead to a second complete remission; neutropenia persisted with a marked left shift of the marrow granulopoiesis. Courses of chemotherapy were given throughout the study. In September 1982, marrow promyelocytes markedly increased, making up 51% of the nucleated cells. One month later the situation was unchanged, and 13-cis-retinoic acid (1 mg/kg) was administered by mouth. Gradually the marrow proportion of promyelocytes decreased to normal levels. The peripheral blood and marrow were still normal after 20 weeks of treatment with retinoic acid. Thus, retinoic acid seemed to have been inducing differentiation in an abnormally increased, maturation-deficient population of promyelocytes in a patient with acute promyelocytic leukaemia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6589010     DOI: 10.1111/j.1365-2141.1984.tb02910.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  19 in total

Review 1.  Acute myelogenous leukaemia in children.

Authors:  S O Lie
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

Review 2.  Differentiation therapy of leukemia: 3 decades of development.

Authors:  Daniel Nowak; Daphne Stewart; H Phillip Koeffler
Journal:  Blood       Date:  2009-02-12       Impact factor: 22.113

3.  Retinoic acid and 6-formylindolo(3,2-b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML.

Authors:  Rodica P Bunaciu; Robert J MacDonald; Holly A Jensen; Feng Gao; Xin Wang; Lynn Johnson; Jeffrey D Varner; Andrew Yen
Journal:  Leuk Lymphoma       Date:  2018-12-20

4.  Top five medical innovations in China mainland since Xinhai revolution [1911]: results of AME survey-002.

Authors:  Yì-Xiáng J Wáng; Fan Xiao
Journal:  Quant Imaging Med Surg       Date:  2015-06

Review 5.  Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.

Authors:  C P Reynolds
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

6.  Repeated complete remission in a patient with acute promyelocytic leukemia after treatment with 13-cis-retinoic acid first and with all-trans-retinoic acid in relapse.

Authors:  T Haferlach; H Löffler; B Glass; W Gassmann
Journal:  Clin Investig       Date:  1993-10

7.  Uptake of retinyl ester in HL-60 cells via the low-density-lipoprotein-receptor pathway.

Authors:  K O Wathne; B Carlander; K R Norum; R Blomhoff
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

8.  Effects of retinoids on in vitro differentiation of bone marrow cells in the myelodysplastic syndrome.

Authors:  R Hast; M Beksac; S Axdorph; A M Sjögren; A Ost; P Reizenstein
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

Review 9.  Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.

Authors:  A Jacobs
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

Review 10.  Differentiation therapy revisited.

Authors:  Hugues de Thé
Journal:  Nat Rev Cancer       Date:  2017-12-01       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.